Fusion contracts boost 3Q revenues for Merge

Merge eFilm says advancing its RIS, PACS and RIS/PACS software has helped fuel sales and earnings in the third quarter of FY04, ending September 30.

Net sales increased 22 percent to $9.30 million, compared with $7.6 million in the third quarter of FY03. Net income was $2.2 million, compared with $1.6 million in the year-ago quarter.

For the nine month period, sales increased 33 percent to $26.9 million, compared with $20.2 million in the first nine months of FY03. Net income was $5.1 million compared with $4.3 million in the year-ago period.

According to Richard A. Linden, president/CEO, third quarter highlights include new and expanded relationships with imaging centers and national chains as well as improving OEM and international VAR business

Merge signed 19 new Fusion contracts in the third quarter of FY04, reinforcing its position in the RIS/PACS software market with 174 Fusion RIS, PACS and RIS/PACS customers representing 366 healthcare facilities, said Merge.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.